OREGON PUBLIC EMPLOYEES RETIREMENT FUND - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 238 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$355,722
-28.6%
13,298
-8.9%
0.01%
-30.0%
Q1 2024$497,938
+7.6%
14,598
-8.8%
0.01%
+25.0%
Q4 2023$462,982
+3.3%
15,998
-1.6%
0.01%
+33.3%
Q3 2023$448,095
-12.1%
16,253
-4.1%
0.01%0.0%
Q2 2023$509,607
-18.9%
16,953
-2.3%
0.01%
-25.0%
Q1 2023$628,699
+0.1%
17,353
-1.4%
0.01%0.0%
Q4 2022$627,899
+5.2%
17,603
-0.2%
0.01%0.0%
Q3 2022$597,000
+18.7%
17,633
+1.3%
0.01%0.0%
Q2 2022$503,000
-22.6%
17,408
-13.4%
0.01%
+14.3%
Q1 2022$650,000
+8.2%
20,108
-2.4%
0.01%0.0%
Q4 2021$601,000
+4.3%
20,608
-4.6%
0.01%0.0%
Q3 2021$576,000
-13.8%
21,608
-0.5%
0.01%0.0%
Q2 2021$668,000
+17.6%
21,7080.0%0.01%0.0%
Q1 2021$568,000
+6.0%
21,708
+1.9%
0.01%0.0%
Q4 2020$536,000
+18.8%
21,308
-1.5%
0.01%0.0%
Q3 2020$451,000
-9.8%
21,639
+2.9%
0.01%0.0%
Q2 2020$500,000
+32.3%
21,0390.0%0.01%0.0%
Q1 2020$378,000
-24.2%
21,0390.0%0.01%0.0%
Q4 2019$499,000
-13.7%
21,0390.0%0.01%
-12.5%
Q3 2019$578,000
-15.4%
21,039
+1.9%
0.01%
-11.1%
Q2 2019$683,000
-3.7%
20,639
+2.0%
0.01%
-10.0%
Q1 2019$709,000
+7.4%
20,239
+1.8%
0.01%0.0%
Q4 2018$660,00019,8730.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders